Conversely, adiponectin is reduced in individuals with obesity, playing an anti-inflammatory, anti-diabetic, and cardioprotective role, underscoring the clinical relevance of hypoadiponectinemia in this population [2,8,9,10,11]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.